Solve FSHD

Solve FSHD is a venture philanthropic organization accelerating novel therapies for Facioscapulohumeral Muscular Dystrophy (FSHD). It strategically invests in leading academic, biotech, and biopharmaceutical entities. Its core approach removes research and development pipeline barriers, fostering a robust ecosystem for new treatments and a comprehensive solution.

Established by the Wilson family, driven by Chip Wilson's personal FSHD connection, the organization originated from the insight that a cure was feasible with concentrated effort and strategic investment. This venture was founded on the principle that direct engagement translates promising research into tangible patient solutions.

Solve FSHD targets the global FSHD patient community, funding research and clinical trials to halt muscle degeneration and promote regeneration. Its mission is to achieve a comprehensive solution for FSHD by December 31, 2027. The long-term vision extends beyond this milestone, providing ongoing support and resources for the patient community worldwide.